I'd like to get one more question in, Minister.
Pharmacare advocates were recently quite alarmed to see you deliver the keynote speech at a Canada 2020 forum on May 14 that was dominated by lobby groups that oppose universal public drug coverage. Doctors who support that coverage called it a one-sided event. Former Liberal health minister Jane Philpott reacted to your speech saying that the one-sided event is problematic and makes her nervous about the government's commitment to pharmacare. It was sponsored by the Canadian Life and Health Insurance Association and Innovative Medicines Canada, which represents Canada's pharmaceutical industry.
Minister, do you agree that your participation in that event was problematic? How do you respond to pharmacare advocates who argue that corporate lobbyists appear to have too much influence on your government's pharmacare deliberations?